Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

NCT01945788 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis With Pathological Fracture

Interventions

DRUG: Teriparatide (rDNA origin)

Sponsor

Bio Sidus SA